The Diabetes Collective

04/24/2026

I show people how to use diabetes technology 💃🏼

Tell me this: How could your devices be better and what’s the One thing we can do better to support you?

04/24/2026

Save this post so you know exactly what to do 💉🩸 and I’d loveeeeee to know, Have you been offered these tests? And if not, are you comfortable asking for them or think you’d be shut down?

_________________________________________________

The Diabetes Collective ®️ by Rachael Sood, NP, CDCES
📍2315 Florida Street, Suite230, Mandeville, La | USA
📱 (985) 373-1148
✉️ contact@thediabetescollective.net
🌎 https://www.thediabetescollective.net

_________________________________________________

04/22/2026

What else is better than collaborating with other T1D Digital Opinion Leaders?!

Our core message: we are here for YOU. Listening. With a purposeful presence on Social Media. It’s our job to educate and provide support to our patients in any way we possibly can. We are patient allies, on a mission to form partnerships within communities and with each other.

Together. this is how we will transform healthcare

04/22/2026

🗣️ Tzield is now approved for ages 1+ and older for the indication of Type 1 diabetes, Stage 2.

This is a big deal as historically this medication had only been approved on insurance plans for ages 8 and older since 2022. During this time, parents haven’t had a choice to give their young children newly diagnosed with T1D other than clinical trial referrals…. Until today!

This was the best news to wake up to. Check out the full interview here, thanks for having me Contemporary Pediatrics https://www.contemporarypediatrics.com/view/rachael-sood-on-the-new-expanded-indication-of-teplizumab

04/22/2026

Earlier today at the office. P.s. I only work with pretty blondes. I’m just kidding! 👄🫶🌴 bit seriously I wanted you to meet Tammy and Hillary. I’m seriously so blessed to know them!

Out of Office For a conference, this was my goodbye this morning, headed to the AACE conference in Vegas 2026 ✈️

04/20/2026

“All about Orforglipron” AKA the new FOUNDAYO tablet,
• a Glp1 non-peptide indicated for weight loss. • Can be taken with or without food so it’s not on a schedule like the other glo1 tablets.
•Low cash pay price point of $149/month rivaling counterfeit and compounded glp1’s sold for cash profit without safety profiles,

Here’s a Preview of my interview with “The Educated Patient”. For the full story listen here:
https://youtube.com/?si=IZpk115MSER13UPr

04/19/2026

Same reason they’re too lazy to learn this new dance… 👄💃🏼✨

Since the science of medicine is continuously evolving, we must too. No doubt it’s hard learning new things especially after forming muscle memory. But we do it for the greater good of humanity.

Screening for Type 1 diabetes should be offered to anyone that has an existing autoimmune or metabolic condition, plus those with any family history of Diabetes. I’ve linked some reputable accounts for you 👌

DM ‘SCREEN ME’ to learn more

___________________________________________________

The Diabetes Collective ®️ by Rachael Sood, NP, CDCES
📍2315 Florida Street, Suite230, Mandeville, La | USA
📱 (985) 373-1148
✉️ contact@thediabetescollective.net
🌎 https://www.thediabetescollective.net

___________________________________________________

04/18/2026

Here’s how you screen for T1D and interpret findings:

• T1 stage 1: 2 or more positive autoantibodies. No abnormal glucose, A1, or glucose tolerance test.
• T1 stage 2: 2 or more positive autoantibodies, abnormal glucose slight (less than 126 fasting but over 100) , Hgba1c elevated but less than 6.5%, + OGTT - greater than 140, but less than 199.
• T1 stage 3: 2 or more positive autoantibodies , abnormal and elevated glucose, elevated Hgba1c greater than 6.5%, and symptomatic requiring insulin.

Once you determine staging, this determines risk and treatment options like Tepluzimab or referral for clinical trials, in addition to metabolic monitoring or is insulin imminent?

Comment SCREEN me for a bigger deep dive with me STK Steakhouse

04/18/2026

Here’s 4 ways to diagnose diabetes👇

1) fasting plasma glucose 126 or greater on two occasions
2) positive oral glucose tolerance test - level of 200 mg/dl or higher after 2 hours of drinking a 75 gram glucose challenge
3) Hgba1c > 6.5%
4) Two positive autoantibodies constitutes a diagnoses of Autoimmune type 1 diabetes

You can use blood testing, cgm, and metabolic monitoring to detect diabetes. Mixed meal tolerance tests, as well as insulin levels and HOMA2-IR can also helpful!

Have you been offered all of these tests or just A1C? Comment “SCREEN ME” or send us a private DM to learn more ✨

___________________________________________

The Diabetes Collective ®️ by Rachael Sood, NP, CDCES
📍2315 Florida Street, Suite230, Mandeville, La | USA
📱 (985) 373-1148
✉️ contact@thediabetescollective.net
🌎 https://www.thediabetescollective.net

___________________________________________

04/17/2026

A list of T1D clinical Trials!

https://www.juiceboxpodcast.com/trials?fbclid=IwZnRzaAROmUdleHRuA2FlbQIxMQBzcnRjBmFwcF9pZAo2NjI4NTY4Mzc5AAEeyarG00lSKg_ETcOiqpwu6CsQXZvjOSJ6rMHW7lf61tWDPg9Jm0tLhRyPW6Q_aem_o0yScAzcmtoCnSjFR9Mt-Q

Explore our comprehensive Type 1 Diabetes Clinical Trial Tracker. Stay updated on the latest T1D research, including advancements in AID systems, beta cell therapies, immunotherapy, and islet transplants. Discover ongoing scientific progress and find clinical trials driving the future of diabetes ca

04/17/2026

Yes this is my stage. But what “stage” are you in? People assume Type 1 means you need insulin, and that’s not true. Autoimmune Type 1 diabetes has 3 stages. And only 1 requires insulin.

All 3 stages are positive for 2 Autoantibodies plus…

Stage 1 - normal blood sugar - no medications
Stage 2- abnormal blood sugars - minimal to no meds
Stage 3- high blood sugars - increasing need and progression to insulin dependence

Fortunately, if we can identify people before they need insulin, we can give them more treatment options now, save time and prevent trauma.

Comment “SCREEN ME” for more info on staging

___________________________________________

The Diabetes Collective ®️ by Rachael Sood, NP, CDCES
📍2315 Florida Street, Suite230, Mandeville, La | USA
📱 (985) 373-1148
✉️ contact@thediabetescollective.net
🌎 https://www.thediabetescollective.net

___________________________________________

04/16/2026

Dear friends. I am making sure you understand this:

That this glp1 has independent proof of cardiac and kidney protection. These are not my opinions. These are straight FACTS.

We are not playing around waiting for people to have heart attacks and strokes or end up in the hospital in active heart failure. The whole point of my job is to keep people OUT of the hospital.

A secondary analysis of the SOUL randomized clinical trial assessed oral in adults with type 2 , atherosclerotic disease, and/or chronic disease, focusing on outcomes by heart failure (HF) status.

Among participants with a history of HF, oral semaglutide reduced the risk of composite HF outcomes—including HF hospitalization, urgent HF visit, or cardiovascular death—compared to placebo, with the greatest reduction observed in HF with preserved ejection fraction. The incidence of serious adverse events was similar between groups, supporting the safety of oral semaglutide in this population.

https://ja.ma/4mxIFgT